123-I-MIP-1072
Sponsors
Molecular Insight Pharmaceuticals, Inc.
Conditions
Prostate Cancer
Phase 1
Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents
CompletedNCT00712829
Start: 2008-05-31End: 2009-01-31Target: 12Updated: 2011-10-12
A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer
CompletedNCT00992745
Start: 2009-10-31End: 2011-09-30Target: 24Updated: 2011-10-12